$***MVP OTC PICKS ALPHABETICALLY***
ANDI -
$***MVP OTC PICKS ALPHABETICALLY***
ANDI - ronshappy
BCAP - Pharaoh
EEDG - Smitter
EPGL - steelerfan7
FSNN - Vickster
ICTY - Chartman17
LUXD - pennymonkey
MDIN - fitzkarz
MDHI - goarmy123
MDMN - 77
MIHL - getmoreshares
RFMK - MattySimone
SEEK - gramps1942
THCB - Roger Wilco
WAFR - Big Tuna
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Unveiling America's Drone Manufacturing Surge Straight talk, folks—there's a roaring play on the horizon with drones, and Neros is right at the spearhead. A fresh $450 million conditional loan from the Office of Strategic Capital (OSC) is lighting up the field, and if you're not paying attention, you're already falling behind. Add $165 million more in cold hard Neros...
Continue Reading
Ah, the thrill of the pre-IPO buzz. Vantage has thrown its hat into the ring with a pre-IPO CFD offering, giving stock jockeys like you and me a chance to express our bullish or bearish convictions before a company goes public. The question is: does this open new doors for the sharp-eyed investor, or are we just adding another layer of risk onto an already wild ride?...
Continue Reading
An Evolving Workplace Demands Evolving Strategies Look, careers ain't what they used to be—and they shouldn't be. Today’s world is flipping the script on how we work, and Dr. Brandi R. Muñoz is rewriting the book on career development with her SPECS framework. The guy clinging to his outdated Rolodex for advice isn't gonna cut it anymore. "Who Are Your SPECS?...
Continue Reading
Pneumonia Vaccines Take a Bold Step GPN Vaccines is steering its course with a US$10 million private placement, aiming to shake up a traditionally complex vaccine market. This clinical-stage biotech is throwing down the gauntlet with Gamma-PN™, its lead candidate that challenges existing serotype-specific pneumococcal vaccines. The big idea? Bypass the mess of adding...
Continue Reading
Lupin's Big Break Let's cut right to the chase: Lupin's latest FDA approval is no small potatoes. It's like getting a golden ticket in the pharma world, especially when you've been in the trenches as long as they have. As the first-to-file for their Amifampridine Tablets, 10 mg, this Indian giant is snagging that sweet 180-day exclusivity window. And in the cutthroat...
Continue Reading
Strengthening the Backbone of Virginia's Power Supply Ever had your lights flicker on a windy day and wondered if the power grid would hold? Potomac Edison, under the banner of FirstEnergy Corp., is stepping up with a game plan to fortify the electric spine of Virginia and its neighbors. They're diving into a multi-state adventure, rebuilding and erecting 138 kV...
Continue Reading
A Concerted Effort for Lung Cancer Awareness Picture this: communities nationwide rallying together, not just to remember but to act against lung cancer. That's exactly what's happening this November, as LUNGevity Foundation spearheads Lung Cancer Awareness Month (LCAM). It’s not just about recognition—it's action with purpose. Driving Change Through Action This...
Continue Reading
Get Real with Pricing: Don't Let Dreams Cloud Sales Ever find yourself caught between hoping for a pot of gold and a real cash windfall? Well, it seems that's exactly where a lot of homeowners stand when the 'For Sale' sign goes up. Enter Frank Van Dresser, a real estate veteran with RE/MAX Quality Realty, who’s talking sense about why overpricing your house might just...
Continue Reading
Pedaling into a New Era of eBikes When the top contender in the American eBike world rolls out something new, you'd better believe it's worth a look. Lectric eBikes has just unwrapped three limited-edition versions of their beloved XP4, revealing a fresh take on a ride already admired by thousands. Let's dig into this new release. What's New with the XP4 This ain't just a...
Continue Reading
Efficiency at the Core of Insurance Operations Gore Mutual Insurance is flipping the script on efficiency in the insurance world. They’ve embedded Guidewire’s ProNavigator right into their claims and underwriting systems to make fast, accurate decisions the new norm. No more scrambling around multiple screens, hunting down policy info—it’s like giving their staff...
Continue Reading
Top 5 Most Recently Viewed Articles
Vicor Introduces Groundbreaking Automotive-Grade Power Modules Vicor has recently unveiled a trio of advanced automotive-grade power modules that promise unmatched power density, fostering the widespread adoption of 48V zonal architectures in vehicles. This innovative product line includes the BCM6135, DCM3735, and PRM3735, each designed to support 48V power distribution,...
Continue Reading
Leadership Changes at NACD Enhance Board Effectiveness Industry veterans bring a wealth of knowledge in governance and innovation. In a landmark move, the National Association of Corporate Directors (NACD) has strengthened its board with the appointments of Jesús Mantas and Wes Bricker. Both distinguished leaders are set to enhance the governance and strategic leadership...
Continue Reading
APLA Health Celebrates a New Milestone Mayor Rex Richardson and Community Leaders Join Grand Reopening Celebration APLA Health is excited to announce the grand reopening of its Long Beach Health Center, following a significant expansion aimed at improving healthcare access for the LGBTQ+ community and other underserved populations. The expanded facility is a testament to...
Continue Reading
Breakthrough in Obstructive Sleep Apnea Treatment with AD109 Apnimed, a clinical-stage pharmaceutical company, has recently made headlines with positive topline results from its second Phase 3 trial of AD109, known as LunAIRo. This trial has demonstrated substantial efficacy in addressing obstructive sleep apnea (OSA), reinforcing the potential of AD109 as the first oral...
Continue Reading
Castle Biosciences Stock Performance Overview Castle Biosciences, Inc. (NASDAQ: CSTL) has recently seen a notable decline in its stock price, falling 14% in a single day. This drop is primarily attributed to mixed reactions to the company’s preliminary performance and the implications of a recent ruling by a key payer. Although the firm announced that it expects to meet...
Continue Reading